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Objectives   This study aimed to investigate whether inpatient multimodal occupational rehabilitation (I-MORE) 
reduces sickness absence (SA) more than outpatient acceptance and commitment therapy (O-ACT) among indi-
viduals with musculoskeletal and mental health disorders. 
Methods   Individuals on sick leave (2-12 months) due to musculoskeletal or common mental health disorders 
were randomized to I-MORE (N=86) or O-ACT (N=80). I-MORE lasted 3.5 weeks in which participants stayed 
at the rehabilitation center. I-MORE included ACT, physical exercise, work-related problem solving and creat-
ing a return to work plan. O-ACT consisted mainly of 6 weekly 2.5 hour group-ACT sessions. We assessed the 
primary outcome cumulative SA within 6 and 12 months with national registry-data. Secondary outcomes were 
time to sustainable return to work and self-reported health outcomes assessed by questionnaires.
Results   SA did not differ between the interventions at 6 months, but after one year individuals in I-MORE had 
32 fewer SA days compared to O-ACT (median 85 [interquartile range 33–149] versus 117 [interquartile range 
59–189)], P=0.034). The hazard ratio for sustainable return to work was 1.9 (95% confidence interval 1.2–3.0) in 
favor of I-MORE. There were no clinically meaningful between-group differences in self-reported health outcomes. 
Conclusions   Among individuals on long-term SA due to musculoskeletal and common mental health disorders, 
a 3.5-week I-MORE program reduced SA compared with 6 weekly sessions of O-ACT in the year after inclusion. 
Studies with longer follow-up and economic evaluations should be performed.
Key terms   cognitive behavioral therapy; fatigue; health services research; inpatient care; musculoskeletal 
 diseases; occupational rehabilitation; physical exercise; problem solving; psychiatry; return to work.
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Musculoskeletal and common mental health disorders 
are the major causes of disability and working years 
lost in the western world (1-4). For musculoskeletal 
disorders, effective occupational rehabilitation programs 
have comprised multimodal interventions including 
components such as physical exercise, psychological/
behavioral therapy, work-related problem solving and 
often involvement and coordination of different stake-
holders (5, 6). For individuals with musculoskeletal or 
common mental health disorders, a recent meta-analysis 
concluded that psychological treatments reduce sick 
leave more than usual care, albeit with small effect sizes, 
and inconclusive results as to which form of psychologi-
cal treatment is the most effective (7). 
The worker`s decision to remain off or return to work 
involves complex interactions between personal beliefs, 
physical, psychosocial, and system factors and goes far 
beyond the medical treatment paradigm for any specific 
diagnosis (8, 9). In addition, co-morbidity between 
musculoskeletal pain and mental health disorders is 
high (10–12). Successful occupational interventions for 
individuals with musculoskeletal disorders have recently 
inspired the development of similar promising interven-
tions for common mental health disorders (5, 13).
Acceptance and commitment therapy (ACT) is a 
recent development within cognitive behavior therapy 
with empirical support as a coping strategy for a broad 
range of clients (14), including for individuals with 
musculoskeletal and common mental health disorders 
(15–17). A Swedish randomized pilot study reported 
fewer sickness absence (SA) days in women with mus-
culoskeletal complaints receiving ACT (18). Further-
more, ACT has successfully been implemented as a 
coping modality in group-based interventions for sick-
listed individuals with different diagnoses (12, 19, 20). 
We have previously compared a short (8 days) inpa-
tient rehabilitation program to group-based outpatient 
ACT (O-ACT) for patients sick-listed due to musculo-
skeletal or common mental health disorders. We found 
no significant differences in SA between this short inpa-
tient program and 6 weeks of O-ACT during one year 
of follow-up (21), and there were negligible differences 
in self-reported health outcomes (22). However, in Nor-
way, 3–4 weeks of inpatient multimodal occupational 
rehabilitation (I-MORE) is common for individuals with 
complex biopsychosocial barriers for return to work. 
Effects of such programs have never been assessed in a 
rigorous design.
The aim of this study was to compare the effect on 
SA of 3.5 weeks I-MORE to the 6 weekly sessions of 
O-ACT. We hypothesized that the more comprehensive 
I-MORE would reduce SA compared to O-ACT.
Method
The Regional Committee for Medical and Health 
Research Ethics in Central Norway approved this open 
label parallel randomized clinical trial (No.: 2012/1241), 
registered in clinicaltrials.gov (No.: NCT01926574), 
and adhered to the CONSORT statement (23). The study 
protocol is published elsewhere (24).
Eligibility criteria
Participants aged 18–60 years sick-listed (2–12 months, 
current sick leave status ≥50%) due to a musculoskeletal, 
psychological, or general and unspecified disorder (eg, 
fatigue) as classified by ICPC-2 (the International Clas-
sification of Primary Care, second edition) were included. 
The exclusion criteria were: (i) alcohol or drug abuse; 
(ii) serious somatic disease (eg, cancer, unstable heart 
disease) or mental disorder (eg, high suicidal risk, psy-
chosis, ongoing manic episode); (iii) disorders requiring 
specialized treatment; (iv) pregnancy; (v) current partici-
pation in another treatment or rehabilitation program; (vi) 
insufficient oral or written Norwegian language skills to 
participate; (vii) surgery scheduled within the next six 
months; and (viii) serious problems with functioning in 
a group setting, as assessed by a multidisciplinary team. 
Recruitment of participants
The Norwegian Labor and Welfare Administration iden-
tified and randomly invited potential participants from 
its records. Potential participants were asked to respond 
to the invitation either in writing or by telephone con-
tact with a project co-worker. The project co-worker 
excluded individuals that self-reported any of the exclu-
sion criteria. We invited the remaining candidates to out-
patient assessment of eligibility consisting of individual 
appointments with a psychologist, a physiotherapist and 
a physician. This multidisciplinary team made a joint 
decision on whether the eligibility criteria were met.
Randomization and blinding
Eligible participants were randomized to either I-MORE 
or O-ACT. The Unit of Applied Clinical Research (third 
party) at the Norwegian University of Science and 
Technology (NTNU) conducted the randomization by 
a flexibly weighted procedure, which ensured that the 
rehabilitation center had enough participants to run 
monthly groups in periods of low recruitment. One of 
the researchers analyzed the primary outcomes while 
blinded to allocation. It was not feasible to blind primary 
researchers in preparation and analysis of the dataset due 
to knowledge of the unequal group sizes.
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Interventions
The I-MORE program was provided at Hysnes rehabilita-
tion center located in a rural setting one-hour travel from 
St. Olavs hospital in the city of Trondheim, Norway. 
I-MORE lasted 3.5 weeks and was more comprehensive 
than O-ACT, which mainly consisted of group-based 
ACT (2.5 hours/week for 6 weeks) at St. Olavs hospital. 
The length of the inpatient and outpatient interventions 
reflected common clinical practice. I-MORE comprised 
various treatment modalities such as physical exercise, 
work-related problem solving and a development of a 
written return-to-work plan in addition to ACT, whereas 
O-ACT consisted mainly of ACT. Mindfulness was 
integrated in several elements within both interventions. 
Details of the two programs are described in table 1 and 
in the protocol article (24). Adherence to- and compe-
tence in ACT was ensured by the same peer reviewed 
ACT trainer through video supervision and mentoring 
of the clinicians in both interventions. 
Outcome measures
The primary outcome measures were the cumulative 
number of SA days (total number of whole workdays 
lost) within 6 and 12 months follow-up (see statistics 
section for details). Secondarily, time until sustainable 
return-to-work (4 weeks without SA) was assessed up to 
12 months. The SA data are based on medically certified 
SA, work assessment allowance and changes in perma-
nent disability pension during follow up, obtained from 
the National Social Security Registry. Employees at the 
Norwegian Labor and Welfare Service registered and pro-
vided SA data. They were blinded to treatment allocation.
Self-reported secondary health outcomes were pain 
(25), anxiety and depression symptoms (26), subjective 
health complaints (27) and health-related quality of 
life (28), all measured as continuous scale scores and 
described in detail previously (21, 22). The participants 
answered web-based questionnaires at baseline, at the 
start and the end of the interventions, and at 3, 6 and 12 
months of follow-up. 
Sample size
The sample size calculations are described in detail else-
where (21, 29). An average SA of 60 [standard deviation 
(SD) 40] and 90 (SD 60) days for I-MORE and O-ACT 
respectively, would require 61 persons for each group. 
We aimed to include 80 persons in each arm allowing 
for 20% attrition or loss to follow-up. 
Statistical analysis
The cumulative number of SA days at 6 and 12 months 
after inclusion were calculated and compared for the 
two programs using the Mann-Whitney U-test (30). 
Sickness absence days were calculated according to a 
5-day workweek adjusted on a monthly basis for part-
time employment, partial sick leave and changes in 
permanent (partial) disability benefits, enabling a count 
of cumulative days compensated with benefits (total 
number of whole workdays lost) (21). We graphically 
displayed differences by plotting the median number 
of SA days in each intervention group as a function of 
time (cumulative median). For time until sustainable 
return to work, Kaplan Meier curves were estimated and 
compared using the log rank test (30). Return-to-work 
hazard ratios  were estimated using the Cox proportional 
hazard model and the Efron method for ties (31), with 
and without adjustment for gender, age, education, 
main diagnosis for sick leave and length of sick leave at 
inclusion. Time was calculated as the number of months 
from inclusion, and participants were censored at the 
first month without SA or at the end of follow-up (12 
months). The proportionality hazards assumption was 
Table 1. Overview of the rehabilitation programs a [ACT= acceptance and commitment therapy; GP=general practitioner.]
Inpatient multimodal occupational rehabilitation (I-MORE) Outpatient acceptance and commitment therapy (O-ACT)
Location Inpatient rehabilitation center Outpatient Hospital clinic
Duration 3.5 weeks (supervised sessions: 45.5 hours) 6–7 weeks (supervised sessions: 18.5 hours)
Contents  
and qualities
- group discussions (×8, total 16 hours; ACT based) 
- psychoeducational sessions (×4, total 6.5 hours) 
- individual meetings with coordinator (×5, total 5 hours) 
- individual meeting with physician (×1, 0.5 hours) 
- supervised physical exercise sessions (×10, total 12 hours) 
- outdoor activities day (×1, 5 hours) 
- “network day” with 2 group sessions (total 4 hours) 
- mindfulness sessions (×7, total 3.5 hours) b 
- “walking to work” (×6, total 3 hours) b 
- create return to work plan 
- at least one weekend at home framed as “home practice” b 
- a resume of the return to work plan was sent to the GP
- weekly ACT group sessions of 2.5 hours duration (×6, total 15 hours led by 
physician or psychologist) 
- group discussion on physical activity (×1, 1 hour led by a physiotherapist) 
- individual sessions (×2, total 2 hours with social worker trained in ACT) 
- individual closing therapy session in week 6 or 7 with both the social 
worker and the group therapist present (×1, 0.5 hours) 
- 15 minutes mindfulness at the start of group sessions (× 6, total 1.5 hours) 
- home practice, including daily mindfulness (15 minutes audio guided) b 
- a short resume of the program content and the patient’s own value based 
action plan was sent to the GP after the individual closing session. 
a Adapted from protocol article; Fimland et al. BMC Public Health 2014.  
b Scheduled but not supervised parts of the program.
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tested using the Schoenfeld Residual test (32). Self-
reported health outcomes were analyzed as repeated 
measurements over time using linear mixed models 
(33), modelled without random slope (only random 
intercept) if the full model did not converge. Analyses 
were performed according to the intention-to-treat prin-
ciple. Additional per protocol analyses were done by 
excluding participants that withdrew after randomization 
(before or during the programs) and/or attended less than 
60% of the sessions of O-ACT.
We performed sensitivity analyses with sustainable 
return to work defined as 2 and 3 months without receiv-
ing benefits. We considered P<0.05 (two-tailed) to be 
statistically significant. Precision of the estimates was 
assessed by 95% confidence intervals (CI). All analyses 
were done using STATA 13.1 (StataCorp, College Sta-
tion, TX, USA).
Results
Of 3808 persons invited to take part in the study, 271 
accepted the invitation and 166 were randomized to 
I-MORE (n=86) or O-ACT (n=80). See figure 1 for 
information about the flow of participants, dropouts and 
missing data.
Participants' characteristics
The mean age of the participants was 46 (SD 9.5) years 
and the majority was women (79%). About 60% of the 
participants did not have education beyond high-school 
level, and the median length of sick-leave reimburse-
ment during the last 12 calendar months prior to inclu-
sion was 210 calendar days (IQR 170-265). Baseline 
characteristics for the two intervention groups showed 
only minor differences (table 2).
Sickness absence and return to work 
The I-MORE participants had a median of 85 (IQR 
33–149) SA days at 12-month follow-up, significantly 
less than the O-ACT group with 117 days (IQR 59–189; 
Mann-Whitney U-test; P=0.034). At 6 months follow-
up, the median number of SA days was 51 (IQR 27–85) 
for I-MORE and 65 (IQR 42–97) O-ACT, respectively 
(Mann-Whitney U-test; P=0.114), see figure 2. 
In total, 50 of the 86 participants in I-MORE and 31 











































Intention to treat analysis for primary outcomes (N=86) (no missing data) 
and secondary outcomes (linear mixed modelling)  
 
Per protocol analysis for primary outcomes (N=69)  
 
Excluded (N=105) 
   Not eligible (N=83)  
Returned to work (N=10); Alcohol/drug abuse (N=1); Serious somatic/psychiatric illness (N=11); Specialized treatment needs (N=4); Participating in another 
treatment program (N=22); Insufficient language skills (N=2); Surgery scheduled next 6 months (N=2); Problems with functioning in groups (N=3).  
Other: Unwilling/unable to leave home for the inpatient intervention (N=7) or lack of motivation (N=6); Further clinical assessment needed (N=15).  
Declined to participate (N=18). 
Unknown reasons (N=4). 
Randomized (N=166) 
I-MORE (N=86) 
  Completed allocated program (N=69)  
  Did not receive allocated program (N=17) 
Withdrawal before start of program (N=15) 
Withdrawal during program (N=2) 
 
Intention to treat analysis for primary outcomes (N=80) (no missing data) 
and secondary outcomes (linear mixed modelling)  
 
Per protocol analysis for primary outcomes (N=61) 
 
Sickness absence registry data complete for all (N=86)  
 
Self-reported health measures (secondary outcomes): 
Baseline (N=86) 
Program start (N=68) 
Program end (N=64) 
  3 months follow-up (N=49) 
  6 months follow-up (N=37) 
12 months follow-up (N=37) 
 
Sickness absence registry data complete for all (N=80) 
 
Self-reported health measures (secondary outcomes): 
Baseline (N=78) 
Program start (N=51) 
Program end (N=44) 
  3 months follow-up (N=38) 
  6 months follow-up (N=30) 
12 months follow-up (N=32) 
 
O-ACT (N=80) 
  Completed allocated program (N=61) 
  Did not receive allocated program (N=19) 
Withdrawal before start of program (N=10) 
Withdrawal during program (N=7) 
Less than 60% attendance (N=2) 
 
Multidisciplinary outpatient team assessment (N=271) b 
 
Sick-listed individuals invited to the study (N=3808) a 
  
Declined (N=939); No answer (N=2312); Letter in return (N=61); Excluded based on self-report (N=225) 
 
b Potential participants were identified and invited by the Norwegian Labour and Welfare Service between October 2012 and November 2014. aFinal decisions 
on eligibility were at the discretion of a multidisciplinary team consisting of a psychologist, a physiotherapist and a physician. I-MORE, Inpatient multimodal 
occupational rehabilitation. O-ACT, Outpatient acceptance and commitment therapy. 
Figure 1. Flow of 
participants in 
the study.
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return to work. Figure 3 shows the Kaplan-Meier plot. 
The difference between the programs was statistically 
significant (log rank test, P=0.009). The unadjusted 
return-to-work hazard ratio was 1.9 (95% CI 1.2–3.0), 
in favor of I-MORE and was unchanged after adjusting 
for age, gender, level of education, length and cause of 
sick leave (1.9; 95% CI 1.2–3.2). 
The sensitivity analyses defining return to work as 2 
and 3 months without receiving benefits showed similar 
hazard ratios (1.8 and 1.7) as the main analyses. 
Per protocol analysis
The median number of SA days during 12 months follow-
up was 90 (IQR 33–170) versus 108 (IQR 58–156) days 
for I-MORE (N=69) and O-ACT (N=61), respectively 
(P=0.30). The respective sustainable return-to-work rates 
were 55% (N=38) and 43% (N=26) and the unadjusted 
hazard ratio was 1.4 (95% CI 0.85–2.44, P=0.17). 
Table 2. Participants' baseline characteristics. [HADS=hospital anxiety 
and depression scale ICPC2=international classification of primary care, 
2nd edition; I-MORE=inpatient multimodal occupational rehabilitation; 
IQR=interquartile range; NRS=numeric rating scale; O-ACT=outpatient 
acceptance and commitment therapy; SD=standard deviation.]
I-MORE (n = 86) O-ACT (n = 80)
Variables N (%) Mean/median 
(SD/IQR)
N (%) Mean/median 
(SD/IQR)
Age a 46.3 (8.7) 45.2 (10.4)
Women a 70 (81) 61 (76)
Higher education  
(university/college) b 
32 (37) 34 (43)
Work status a, b 
No work 11 (13) 6 (8)
Full time 54 (63) 53 (66)
Part time  21 (24) 21 (26)
Graded disability pension c 9 (10) 6 (8)
Sick leave status at inclusion a 
Full sickness benefit 35 (41) 36 (45)
Partial sickness benefit 48 (56) 38 (48)
Work assessment allow-
ance d 
3 (3) 6 (8)
Length of sick leave at  
inclusion a, e
204 (163–265) 216 (177–265)
Sick leave diagnoses (ICPC-2) a
Musculoskeletal diagnosis 54 (63) 40 (50)
Psychological diagnosis f 32 (37) 40 (50)
Anxiety HADS score (0–21) b 7.4 (3.9) 8.6 (4.1)
Depression HADS score 
(0–21) b
5.7 (4.2) 6.6 (4.0)
Average pain NRS (0–10)  
last week b
5.0 (2.0) 4.8 (2.2)
Strongest pain NRS (0–10)  
last week b
6.5 (1.9) 6.2 (2.5)
a Based on registry data. 
b Based on self-reported data. 
c Individuals working ≥50% at inclusion alongside graded permanent dis-
ability pension.
d Work assessment allowance is a medical benefit usually received after reach-
ing the maximum of one year on sick leave benefits in Norway. 
e Number of days on sick leave during the last 12 months prior to inclusion. 
Measured as calendar days, not adjusted for partial sick leave. 
f Four I-MORE and nine O-ACT participants with fatigue and one I-MORE par-
ticipant with perinatal distress included here. 
 
Self-reported health and quality of life 
There were no statistically significant differences 
between the programs in these secondary outcomes 
during 12 months of follow-up, except for a small differ-
ence in average pain in favor of O-ACT (estimated mean 
difference -0.95, 95% CI -1.7– -0.2 on a 0–10 numeric 
rating scale).  Both groups improved anxiety, depression, 
and quality of life outcomes during follow up (table 3).
Discussion
As hypothesized, I-MORE reduced SA more than 
O-ACT, and the time to sustainable return to work was 
 
Figure 3. Time to sustainable return to work (Kaplan-Meier survival analysis) 
for participants in inpatient multimodal occupational rehabilitation (I-MORE) 
and outpatient acceptance and commitment therapy (O-ACT)
Figure 2. Sickness absence days during 12 months of follow up (cumulative 
median) for participants in inpatient multimodal occupational rehabilitation 
(I-MORE) and outpatient acceptance and commitment therapy (O-ACT). 
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shorter for I-MORE. Self-reported health outcomes 
(pain, distress and health-related quality of life) were 
largely similar between the groups during one year of 
follow up.
Our previous investigation of a shorter (8 days) 
inpatient program did not reduce SA compared to 
O-ACT (21). We are not aware of other studies that 
have examined the effect of a comprehensive inpa-
tient occupational rehabilitation program comparable 
to our current study. In Norway, an intensive outpatient 
program consisting of six hours of daily activities for 
four weeks showed no overall effect on return to work 
compared to ordinary treatment in primary care (34). 
However, the same research group later reported that the 
individuals with the most complex problems returned 
to work faster when given the intensive rehabilitation 
program (35). Also, in a Norwegian study providing 
work-focused cognitive therapy combined with job 
support to individuals with common mental disorders, 
only the sub-group of individuals with the most complex 
problems and the longest SA benefitted from the inter-
vention, and the effect on increased work participation 
was sustained after 4 years of follow up (36). Similar to 
the aforementioned studies (35, 36), the individuals in 
our study were long-term sickness absent (median 210 
days in the preceding year). 
Several factors could explain the superiority of 
I-MORE versus O-ACT impact on SA. As this study 
did not utilize a factorial design, it is not possible to 
ascribe the superiority of I-MORE to specific contrasts. 
The most notable differences between the programs 
were that I-MORE was inpatient, more intensive and 
multimodal – incorporating physical exercise and psy-
choeducational sessions. Living at the rehabilitation 
center for 3.5 weeks provided a break from daily life 
and gave more time for contemplation, discussion with 
peers, and integration of new coping strategies. The 
regulated schedule and a fixed wake-up time may have 
provided a frame for improved sleep and better cop-
ing with fatigue (37, 38). Psychoeducational sessions 
alone did not enhance return to work in a Danish study 
(39), but in synergy with other components of an inpa-
tient multimodal intervention it might have contributed 
positively. We previously reported that a sub-sample of 
Table 3. Self-reported health outcomes. Numbers are estimates from unadjusted linear mixed models with random intercept and slope. I-MORE=inpatient 
multimodal occupational rehabilitation; O-ACT=outpatient acceptance and commitment therapy; CI=confidence interval.]
Follow-up times I-MORE (n=86) O-ACT (n=80) Effect estimates a 
Mean 95% CI Mean 95% CI Mean 95% CI
Quality of life b (0–1) c Start intervention 0.78 0.76–0.80 0.77 0.74–0.79
3 months 0.82 0.80–0.85 0.81 0.78–0.83
6 months 0.82 0.80–0.84 0.82 0.79–0.85
12 months 0.82 0.79–0.85 0.83 0.80–0.86 -0.02 -0.06–0.02
Depression b (0–21) d Baseline 5.7 4.9–6.6 6.6 5.7–7.5
Start intervention 5.9 5.0–6.8 7.1 6.1–8.0
End intervention 4.9 4.1–5.8 6.0 5.0–7.0
3 months 4.8 3.8–5.8 6.0 4.9–7.0
12 months 4.7 3.5–5.9 5.1 3.8–6.3 -0.72 -2.3–0.9
Anxiety b (0–21) d Baseline 7.4 6.5–8.2 8.6 7.7–9.5
Start intervention 7.7 6.8–8.5 8.4 7.4–9.3
End intervention 6.3 5.4–7.2 8.3 7.3–9.3
3 months 6.3 5.4–7.3 7.9 6.9–9.0
12 months 6.1 5.0–7.2 6.6 5.4–7.8 -0.22 -1.7–1.3
Average pain b (0–10) e Baseline 5.0 4.5–5.4 4.8 4.4–5.3
Start intervention 4.5 4.0–4.9 4.6 4.1–5.1
End intervention 4.1 3.7–4.6 4.5 4.0–5.0
3 months 4.5 4.0–5.0 4.2 3.7–4.8
12 months 4.7 4.1–5.3 3.9 3.2–4.5 -0.95 -1.7– -0.2
Strongest pain f (0–10) e Baseline 6.5 6.0–6.9 6.2 5.7–6.7
Start intervention 5.8 5.3–6.3 5.7 5.2–9.3
End intervention 5.7 5.2–6.3 5.6 5.0–6.2
3 months 5.9 5.3–6.5 5.8 5.2–6.5
12 months 5.8 5.1–6.6 5.0 4.2–5.8 -0.82 -1.9–0.3
Health complaints  (0–87) g Start intervention 16 14–18 17 15–20
3 months 15 13–17 16 14–18
12 months 15 13–17 16 14–18 -0.35 -3.1–2.4
a Estimated mean differences from start of intervention, I-MORE minus O-ACT. 
b Improvement for both interventions over time (P<0.05). 
c Measured by 15D. 
d Measured by the Hospital Anxiety and Depression Scale. 
e Measured by numeric rating scale (pain last week). 
f Improvement over time for O-ACT (P=0.01).
g Measured by the Subjective Health Complaints Inventory total score (modelled with random intercept only due to lack of convergence).
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participants in I-MORE improved their cardiorespiratory 
fitness during the program, and increased further after a 
year (40). Still, we found little support that differences 
in self-reported health outcomes (table 3), or changes in 
expectancies about return to work (41), could explain 
the differences in SA between programs. This is in line 
with other studies observing that returning to work and 
improving health outcomes are not necessarily concur-
rent events (42, 43). Moreover, participants in O-ACT 
did not create a return-to-work plan, but an action plan 
in accordance with their most important values. This 
may also explain why I-MORE improved work out-
comes compared with O-ACT. 
Workplace involvement is considered a critical fac-
tor in effective return to work programs (6), but our 
results suggest that I-MORE interventions can be suc-
cessful without this component. Another study from our 
group provided no evidence that adding a workplace 
intervention could further improve work participation 
outcomes (44). Finally, also considering our previous 
negative findings of a shorter inpatient program (21), 
our results support the current practice in Norway of 3–4 
weeks of inpatient occupational rehabilitation. 
A particular strength of this randomized study is 
the use of high-quality sick leave registry data, which 
assured complete data regarding SA and return to work. 
In contrast, less than half of the participants answered 
the questionnaires at the 12-month follow-up. Assuming 
missing at random, the mixed-model approach alleviates 
this problem by applying likelihood-based analyses using 
all available data (33). The number of missing question-
naires were fairly similar for the two groups at 6 and 12 
months, but we cannot disregard the possibility of an 
attrition bias for the secondary outcomes. Blinding of 
participants and caregivers regarding allocation was not 
feasible. Primary researchers were not blinded in prepa-
ration of the dataset. However, one of the authors were 
blinded to allocation and performed a separate analysis 
of the primary outcome measures before commencing 
with further analyses and discussing the findings. More-
over, the employees at the Norwegian Labor and Welfare 
Service that prospectively register SA data were unaware 
of group allocation. Another particular strength of the 
study design was that the Norwegian Labor and Welfare 
Service invited participants among those fitting the eligi-
bility criteria in the registry, eliminating referral bias and 
potentially increasing the external validity of the results. 
However, only 38% (of 3808 invited) responded, and only 
271 underwent a full clinical multidisciplinary eligibility 
assessment (figure 1). Since we do not know how many 
of those not responding that would have fulfilled the 
eligibility criteria, we cannot rule out a “self-selection” 
bias, possibly limiting the generalizability of the results 
to situations with similar recruitment methods. Another 
issue is that participants had to be willing to leave their 
home for 3.5 weeks to participate in I-MORE. Moreover, 
the differences in SA diminished in the per protocol analy-
sis. This could be explained by the different patterns of 
withdrawal in I-MORE (before start) and O-ACT (dur-
ing the intervention). It is conceivable that individuals 
that were able to return to work when the intervention 
started, would opt for this rather than 3.5 weeks of inpa-
tient rehabilitation. Conversely, weekly O-ACT could be 
combined with work, making it unnecessary to withdraw 
before the program started. In addition, individuals who 
were unable to participate once a week were probably 
those least able to work. A limitation of our study is that 
we have no information on how O-ACT would have 
compared to usual care. Another limitation is that no 
scoring of therapists' adherence to or competence in ACT 
was done. However, the same peer-reviewed ACT trainer 
supervised clinicians in both interventions. In addition, a 
focus group interview study showed that all the relevant 
ACT processes of behavioral change were reflected in the 
I-MORE participants’ experiences (20).
Finally, since legislation, social security systems and 
occupational rehabilitation services differ extensively 
between countries; one should consider contextual fac-
tors before implementing this intervention, especially 
in parts of the world other than the Nordic countries.
Concluding remarks
Among individuals on long-term SA due to musculo-
skeletal or common mental health disorders, I-MORE 
over 3.5 weeks reduced SA compared with 6 weekly 
sessions of O-ACT in the year after inclusion. Studies 
with longer follow-up and economic evaluations should 
be performed. 
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